InspireMD, Inc.
NSPR· Nasdaq
NSPRInspireMD, Inc.
Released Nov 8, 2021, after the close
10-Q filed Nov 8, 2021, 39 days after period end · 0001493152-21-027504
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Revenue | $1.07M | $980.00K | $939.00K | $769.00K |
| Net Income | -$4.07M | -$2.23M | -$2.07M | -$2.01M |
| EPS Diluted | -$0.53 |
InspireMD, Inc. · CIK 1433607 · Engraved from SEC EDGAR
| -$0.96 |
| -$1.26 |
| -$2.47 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
